TRQ-19975-09459
2 vaccinations
5 coded responses
24 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 604 / IL
- Registered
- 2021-06-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-30
Registered in v-safe
-
2021-06-30
Dose 1 — Pfizer-BioNTech
- 2021-06-30
- 2021-07-01
- 2021-07-02
- 2021-07-03
- 2021-07-04
-
2021-07-05
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Headache · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Runny nose, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-05
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-06
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Runny nose, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-07
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend schoolFree text: Runny nose, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-08
- 2021-07-08
-
2021-07-14
Survey response — day 14, dose 1MedDRA: Upper respiratory tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Upper respiratory infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-19
- 2021-07-21
- 2021-07-29
-
2021-08-13
Dose 2 — Pfizer-BioNTech
- 2021-08-13
- 2021-08-15
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-27
- 2021-09-03
- 2021-09-10
- 2021-09-17
- 2021-09-24
- 2021-11-12
-
2022-02-11
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-13 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose, sore throat
Systemic reaction (other): Runny nose, congestion
Release 9 — day 7, dose 1
Systemic reaction (other): Runny nose, congestion
Release 9 — day 14, dose 1
Symptoms: Upper respiratory infection
Release 11 — 6 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release